Lawsuit Overview
An investor, who currently holds shares of PharMerica Corporation (NYSE:PMC), filed a lawsuit in effort to halt the proposed takeover of PharMerica Corporation for $29.25 per share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NYSE:PMC stockholders by agreeing to sell PharMerica Corporation cheaply via an unfair process. On August 2, 2017, PharMe...
You must register (for free) or login to view the entire case.